Related Experiment Video
Updated: Jun 1, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
An update on selective estrogen receptor modulator: repurposing and formulations.
Riya Patel1, Vanessa James2, Bhupendra Prajapati3,4
1School of Pharmacy, Indrashil University, Rajpur, Kadi, Gujarat, 382715, India.
Raloxifene hydrochloride (RLH), a SERM, shows promise for drug repurposing. This review details advanced formulation strategies, patents, and analytical methods to optimize RLH
Area of Science:
- Pharmacology
- Drug Discovery
- Medicinal Chemistry
Background:
- Raloxifene hydrochloride (RLH), a selective estrogen receptor modulator (SERM), is a key therapeutic agent for breast cancer and osteoporosis.
- Emerging clinical evidence suggests potential repurposing of RLH for diverse pathological conditions.
- Optimizing RLH's clinical utility necessitates a comprehensive understanding of its formulation, patent landscape, and analytical characterization.
Purpose of the Study:
- To provide a detailed review of raloxifene hydrochloride (RLH) drug repurposing.
- To explore the latest formulation strategies, patent advancements, and analytical methodologies for RLH.
- To identify current challenges and propose future research directions for RLH development.
Main Methods:
- Comprehensive literature analysis focusing on RLH repurposing and analytical techniques.
- Review of patent databases to identify key innovations and trends.
- Evaluation of formulation techniques, including advanced drug delivery systems.
Main Results:
- Sophisticated analytical techniques (spectroscopic, chromatographic, electrochemical) enhance RLH measurement and quality control.
- The patent landscape reveals significant innovation in RLH formulations, particularly for improved solubility and bioavailability.
- Advanced formulation techniques like transdermal patches and nanoparticulate systems offer improved therapeutic efficacy and overcome conventional limitations.
Conclusions:
- Raloxifene hydrochloride (RLH) exhibits significant potential for drug repurposing across various diseases.
- Innovations in formulation and analytical techniques are crucial for maximizing RLH's therapeutic benefits.
- Further research into novel drug delivery systems and expanded clinical applications of RLH is warranted.
More Related Videos
Related Concept Videos
Internal Receptors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Dose-Response Relationship: Selectivity and Specificity
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Targeted Cancer Therapies
There are several types of targeted therapies against...

